Eli Lilly & Co., is looking to a bevy of new medicines now in development to repair a pipeline depleted by the company’s recent loss of key exclusive patents. But long R&D and regulatory lead times before a drug hits the market has placed near-term revenue forecasts for the drugmaker under a cloud. Indianapolis-based Lilly may need acquisitions to boost its prospects.
Help employers find you! Check out all the jobs and post your resume.
